The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Thalassemia-Global Market Insights and Sales Trends 2025
Synopsis
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen. The disorder results in large numbers of red blood cells being destroyed, which leads to anemia.
The global Thalassemia market size is expected to reach US$ 5386 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Thalassemia in various end use industries. The expanding demands from the Hospital, Clinic, Research Institute and Laboratories, are propelling Thalassemia market. Iron Chelating Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thalassemia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thalassemia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thalassemia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thalassemia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thalassemia covered in this report include Bluebird bio, Inc., Acceleron Pharma, Inc., Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company and IONIS Pharmaceuticals, etc.
The global Thalassemia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Global Thalassemia market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thalassemia market, Segment by Type:
Iron Chelating Drugs
Others
Global Thalassemia market, by Application
Hospital
Clinic
Research Institute
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thalassemia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen. The disorder results in large numbers of red blood cells being destroyed, which leads to anemia.
The global Thalassemia market size is expected to reach US$ 5386 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Thalassemia in various end use industries. The expanding demands from the Hospital, Clinic, Research Institute and Laboratories, are propelling Thalassemia market. Iron Chelating Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thalassemia, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thalassemia market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thalassemia market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thalassemia sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thalassemia covered in this report include Bluebird bio, Inc., Acceleron Pharma, Inc., Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company and IONIS Pharmaceuticals, etc.
The global Thalassemia market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Global Thalassemia market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thalassemia market, Segment by Type:
Iron Chelating Drugs
Others
Global Thalassemia market, by Application
Hospital
Clinic
Research Institute
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thalassemia companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Thalassemia
1.1 Thalassemia Market Overview
1.1.1 Thalassemia Product Scope
1.1.2 Thalassemia Market Status and Outlook
1.2 Global Thalassemia Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Thalassemia Market Size by Region (2018-2029)
1.4 Global Thalassemia Historic Market Size by Region (2018-2023)
1.5 Global Thalassemia Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Thalassemia Market Size (2018-2029)
1.6.1 North America Thalassemia Market Size (2018-2029)
1.6.2 Europe Thalassemia Market Size (2018-2029)
1.6.3 Asia-Pacific Thalassemia Market Size (2018-2029)
1.6.4 Latin America Thalassemia Market Size (2018-2029)
1.6.5 Middle East & Africa Thalassemia Market Size (2018-2029)
2 Thalassemia Market by Type
2.1 Introduction
2.1.1 Iron Chelating Drugs
2.1.2 Others
2.2 Global Thalassemia Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Thalassemia Historic Market Size by Type (2018-2023)
2.2.2 Global Thalassemia Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Thalassemia Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Thalassemia Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Thalassemia Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Thalassemia Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Thalassemia Revenue Breakdown by Type (2018-2029)
3 Thalassemia Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Research Institute
3.1.4 Laboratories
3.1.5 Others
3.2 Global Thalassemia Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Thalassemia Historic Market Size by Application (2018-2023)
3.2.2 Global Thalassemia Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Thalassemia Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Thalassemia Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Thalassemia Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Thalassemia Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Thalassemia Revenue Breakdown by Application (2018-2029)
4 Thalassemia Competition Analysis by Players
4.1 Global Thalassemia Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thalassemia as of 2022)
4.3 Date of Key Players Enter into Thalassemia Market
4.4 Global Top Players Thalassemia Headquarters and Area Served
4.5 Key Players Thalassemia Product Solution and Service
4.6 Competitive Status
4.6.1 Thalassemia Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bluebird bio, Inc.
5.1.1 Bluebird bio, Inc. Profile
5.1.2 Bluebird bio, Inc. Main Business
5.1.3 Bluebird bio, Inc. Thalassemia Products, Services and Solutions
5.1.4 Bluebird bio, Inc. Thalassemia Revenue (US$ Million) & (2018-2023)
5.1.5 Bluebird bio, Inc. Recent Developments
5.2 Acceleron Pharma, Inc.
5.2.1 Acceleron Pharma, Inc. Profile
5.2.2 Acceleron Pharma, Inc. Main Business
5.2.3 Acceleron Pharma, Inc. Thalassemia Products, Services and Solutions
5.2.4 Acceleron Pharma, Inc. Thalassemia Revenue (US$ Million) & (2018-2023)
5.2.5 Acceleron Pharma, Inc. Recent Developments
5.3 Celgene Corporation
5.3.1 Celgene Corporation Profile
5.3.2 Celgene Corporation Main Business
5.3.3 Celgene Corporation Thalassemia Products, Services and Solutions
5.3.4 Celgene Corporation Thalassemia Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline plc Recent Developments
5.4 GlaxoSmithKline plc
5.4.1 GlaxoSmithKline plc Profile
5.4.2 GlaxoSmithKline plc Main Business
5.4.3 GlaxoSmithKline plc Thalassemia Products, Services and Solutions
5.4.4 GlaxoSmithKline plc Thalassemia Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline plc Recent Developments
5.5 Incyte Corporation
5.5.1 Incyte Corporation Profile
5.5.2 Incyte Corporation Main Business
5.5.3 Incyte Corporation Thalassemia Products, Services and Solutions
5.5.4 Incyte Corporation Thalassemia Revenue (US$ Million) & (2018-2023)
5.5.5 Incyte Corporation Recent Developments
5.6 Gamida Cell
5.6.1 Gamida Cell Profile
5.6.2 Gamida Cell Main Business
5.6.3 Gamida Cell Thalassemia Products, Services and Solutions
5.6.4 Gamida Cell Thalassemia Revenue (US$ Million) & (2018-2023)
5.6.5 Gamida Cell Recent Developments
5.7 Kiadis Pharma
5.7.1 Kiadis Pharma Profile
5.7.2 Kiadis Pharma Main Business
5.7.3 Kiadis Pharma Thalassemia Products, Services and Solutions
5.7.4 Kiadis Pharma Thalassemia Revenue (US$ Million) & (2018-2023)
5.7.5 Kiadis Pharma Recent Developments
5.8 La Jolla Pharmaceutical Company
5.8.1 La Jolla Pharmaceutical Company Profile
5.8.2 La Jolla Pharmaceutical Company Main Business
5.8.3 La Jolla Pharmaceutical Company Thalassemia Products, Services and Solutions
5.8.4 La Jolla Pharmaceutical Company Thalassemia Revenue (US$ Million) & (2018-2023)
5.8.5 La Jolla Pharmaceutical Company Recent Developments
5.9 IONIS Pharmaceuticals
5.9.1 IONIS Pharmaceuticals Profile
5.9.2 IONIS Pharmaceuticals Main Business
5.9.3 IONIS Pharmaceuticals Thalassemia Products, Services and Solutions
5.9.4 IONIS Pharmaceuticals Thalassemia Revenue (US$ Million) & (2018-2023)
5.9.5 IONIS Pharmaceuticals Recent Developments
6 North America
6.1 North America Thalassemia Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Thalassemia Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Thalassemia Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Thalassemia Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Thalassemia Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Thalassemia Market Dynamics
11.1 Thalassemia Industry Trends
11.2 Thalassemia Market Drivers
11.3 Thalassemia Market Challenges
11.4 Thalassemia Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
